111 related articles for article (PubMed ID: 16112651)
1. Leukomogenic factors downregulate heparanase expression in acute myeloid leukemia cells.
Eshel R; Ben-Zaken O; Vainas O; Nadir Y; Minucci S; Polliack A; Naparstek E; Vlodavsky I; Katz BZ
Biochem Biophys Res Commun; 2005 Oct; 335(4):1115-22. PubMed ID: 16112651
[TBL] [Abstract][Full Text] [Related]
2. The Leukemia-associated ETO homologues are differently expressed during hematopoietic differentiation.
Lindberg SR; Olsson A; Persson AM; Olsson I
Exp Hematol; 2005 Feb; 33(2):189-98. PubMed ID: 15676213
[TBL] [Abstract][Full Text] [Related]
3. The integrity of the charged pocket in the BTB/POZ domain is essential for the phenotype induced by the leukemia-associated t(11;17) fusion protein PLZF/RARalpha.
Puccetti E; Zheng X; Brambilla D; Seshire A; Beissert T; Boehrer S; Nürnberger H; Hoelzer D; Ottmann OG; Nervi C; Ruthardt M
Cancer Res; 2005 Jul; 65(14):6080-8. PubMed ID: 16024608
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-simulating agents and selective stimulation of arsenic trioxide-induced growth arrest and cell differentiation in acute promyelocytic leukemic cells.
Yan H; Peng ZG; Wu YL; Jiang Y; Yu Y; Huang Y; Zhu YS; Zhao Q; Chen GQ
Haematologica; 2005 Dec; 90(12):1607-16. PubMed ID: 16330433
[TBL] [Abstract][Full Text] [Related]
6. Pro-proliferative function of the long isoform of PML-RARalpha involved in acute promyelocytic leukemia.
Tussié-Luna MI; Rozo L; Roy AL
Oncogene; 2006 Jun; 25(24):3375-86. PubMed ID: 16434964
[TBL] [Abstract][Full Text] [Related]
7. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
Xu M; Li D; Lu Y; Chen GQ
Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
[TBL] [Abstract][Full Text] [Related]
8. The serine-threonine kinase MNK1 is post-translationally stabilized by PML-RARalpha and regulates differentiation of hematopoietic cells.
Worch J; Tickenbrock L; Schwäble J; Steffen B; Cauvet T; Mlody B; Buerger H; Koeffler HP; Berdel WE; Serve H; Müller-Tidow C
Oncogene; 2004 Dec; 23(57):9162-72. PubMed ID: 15516979
[TBL] [Abstract][Full Text] [Related]
9. Programmed cell death-4 tumor suppressor protein contributes to retinoic acid-induced terminal granulocytic differentiation of human myeloid leukemia cells.
Ozpolat B; Akar U; Steiner M; Zorrilla-Calancha I; Tirado-Gomez M; Colburn N; Danilenko M; Kornblau S; Berestein GL
Mol Cancer Res; 2007 Jan; 5(1):95-108. PubMed ID: 17259349
[TBL] [Abstract][Full Text] [Related]
10. The methyl-CpG binding protein MBD1 is required for PML-RARalpha function.
Villa R; Morey L; Raker VA; Buschbeck M; Gutierrez A; De Santis F; Corsaro M; Varas F; Bossi D; Minucci S; Pelicci PG; Di Croce L
Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1400-5. PubMed ID: 16432238
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic heterochromatin markers distinguish terminally differentiated leukocytes from incompletely differentiated leukemia cells in human blood.
Popova EY; Claxton DF; Lukasova E; Bird PI; Grigoryev SA
Exp Hematol; 2006 Apr; 34(4):453-62. PubMed ID: 16569592
[TBL] [Abstract][Full Text] [Related]
12. HDAC4 mediates transcriptional repression by the acute promyelocytic leukaemia-associated protein PLZF.
Chauchereau A; Mathieu M; de Saintignon J; Ferreira R; Pritchard LL; Mishal Z; Dejean A; Harel-Bellan A
Oncogene; 2004 Nov; 23(54):8777-84. PubMed ID: 15467736
[TBL] [Abstract][Full Text] [Related]
13. Retinoic acid receptors, hematopoiesis and leukemogenesis.
Collins SJ
Curr Opin Hematol; 2008 Jul; 15(4):346-51. PubMed ID: 18536573
[TBL] [Abstract][Full Text] [Related]
14. SSBP2, a candidate tumor suppressor gene, induces growth arrest and differentiation of myeloid leukemia cells.
Liang H; Samanta S; Nagarajan L
Oncogene; 2005 Apr; 24(16):2625-34. PubMed ID: 15782145
[TBL] [Abstract][Full Text] [Related]
15. Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Trnková Z; Bedrlíková R; Marková J; Michalová K; Stöckbauer P; Schwarz J
Neoplasma; 2007; 54(5):383-90. PubMed ID: 17688368
[TBL] [Abstract][Full Text] [Related]
16. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
17. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibitor treatment downregulates VLA-4 adhesion in hematopoietic stem cells and acute myeloid leukemia blast cells.
Mahlknecht U; Schönbein C
Haematologica; 2008 Mar; 93(3):443-6. PubMed ID: 18268283
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of c-Myc determines sensitivity to 2-methoxyestradiol-induced apoptosis in human acute myeloid leukemia.
Chow JM; Liu CR; Lin CP; Lee CN; Cheng YC; Lin S; Liu HE
Exp Hematol; 2008 Feb; 36(2):140-8. PubMed ID: 18206725
[TBL] [Abstract][Full Text] [Related]
20. Association of heparanase gene (HPSE) single nucleotide polymorphisms with hematological malignancies.
Ostrovsky O; Korostishevsky M; Levite I; Leiba M; Galski H; Vlodavsky I; Nagler A
Leukemia; 2007 Nov; 21(11):2296-303. PubMed ID: 17611567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
